---
$id: https://graph.org.ai/products/commodity/51141597
$type: Product
source: UNSPSC
code: "51141597"
title: "Tiagabine hydrochloride"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tiagabine hydrochloride

**UNSPSC Code**: 51141597
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C20H25NO2S2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DQH6T6D8OY, chemically known as 3-piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-yl)-, hydrochloride, (r)- but more generally known as tiagabine hydrochloride, which bears US NIH Compound Identifier 91274. European Medicines Agency schedules Tiagabine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15566MIG. Most nations, for tariff and trade purposes, schedule tiagabine hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, TIAGABINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tiagabine hydrochloride bears US NLM identifiers UMLS ID C0772200 and NCI Concept Code C47755. SMILES: CC1CCSC1C(=CCCN2CCC[C@H](C2)C(=O)O)C3C(CCS3)C.CL.

